Skip to Main Content

Paper Details

Depot-Medroxyprogesterone Acetate Use Is Associated with Decreased Risk of Ovarian Cancer: The Mounting Evidence of a Protective Role of Progestins.
Cancer Epidemiol Biomarkers Prev
9
2021
DMPA, Medroxyprogesterone Acetate, Ovarian Cancer, Progestins, invasive epithelial ovarian cancer, medroxyprogesterone acetate, ovarian cancer, progestin, women
Author NameAffiliation
Anna H WuKeck School of Medicine, University of Southern California
Anna H WuKeck School of Medicine, University of Southern California
Andrew BerchuckDuke University School of Medicine
Jennifer A DohertyHuntsman Cancer Institute, University of Utah
Jennifer A DohertyHuntsman Cancer Institute, University of Utah
Marc T GoodmanSamuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Holly R HarrisFred Hutchinson Cancer Research Center
Bhramar MukherjeeUniversity of Michigan School of Public Health ann arbor
Bhramar MukherjeeUniversity of Michigan School of Public Health ann arbor
Joellen M SchildkrautEmory University Rollins School of Public Health
Malcolm C PikeKeck School of Medicine, University of Southern California
Malcolm C PikeMemorial Sloan Kettering Cancer Center
Malcolm C PikeKeck School of Medicine, University of Southern California
Malcolm C PikeMemorial Sloan Kettering Cancer Center
  • 1 - 14

Datasets

Release 1.2